Last updated on May 2018

A Study of INCB050465 in Subjects With Relapsed or Refractory Marginal Zone Lymphoma (CITADEL-204)


Brief description of study

The purpose of this study is to evaluate the safety and efficacy of two INCB050465 treatment regimens in participants diagnosed with relapsed or refractory marginal zone lymphoma (MZL) who are naive to or were previously treated with a Bruton's tyrosine kinase (BTK) inhibitor.

Clinical Study Identifier: NCT03144674

Contact Investigators or Research Sites near you

Start Over

Dr. Mehta

University of Alabama at Birmingham Comprehensive Cancer Center
Birmingham, AL United States
  Connect »

Dr. Karamlou

Arizona Oncology Associates - Biltmore Cancer Center
Phoenix, AZ United States
  Connect »

Dr. Stanton

St. Joseph Heritage Healthcare
Petaluma, CA United States
  Connect »

Dr. Sikaria

Torrance Health Association
Redondo Beach, CA United States
  Connect »

Dr. Greenwald

Sansum Clinical
Santa Barbara, CA United States
  Connect »

Dr. Cheung

Innovative Clinical Research Institute
Whittier, CA United States
  Connect »

Dr. Armas

Valley View Hospital
Glenwood Springs, CO United States
  Connect »

Dr. Geronilla

Advanced Pharma - Miami
Miami, FL USA
  Connect »

Dr. Tache

Boca Raton Clinical Research Associates, Inc
Plantation, FL United States
  Connect »

Dr. Caradonna

Asclepes Research Centers
Spring Hill, FL United States
  Connect »

Dr. Khan

Clinical Trials of SWLA, LLC
Lake Charles, LA United States
  Connect »

Dr. Phillips

University of Michigan Cancer Center
Ann Arbor, MI United States
  Connect »

Dr. Janakiraman

Henry Ford Hospital
Detroit, MI United States
  Connect »

Dr. Kingsley

Comprehensive Cancer Centers of Nevada
Las Vegas, NV United States
  Connect »

Dr. Coleman

Clinical Research Alliance
Lake Success, NY United States
  Connect »

Dr. Cohen

Hematology Oncology Associates of Rockland
Nyack, NY United States
  Connect »

Dr. Cho

White Plains Hospital
White Plains, NY United States
  Connect »

Dr. Gabrail

Gabrail Cancer Research Center
Canton, OH United States
  Connect »

Dr. Ellison

Charleston Hematology Oncology Associates
Charleston, SC United States
  Connect »

Dr. Crow

Renovatio Clinical
Houston, TX United States
  Connect »

Dr. Tjan-Wettstein

St. Mary's Medical Center
Santa Barbara, CA United States
  Connect »

Dr. Dichmann

Mission Hope Cancer Center
Santa Maria, CA United States
  Connect »

Dr. Lossos

University of Miami, SCCC
Miami, FL United States
  Connect »

Dr. Venugopal

Rush University Medical Center
Chicago, IL United States
  Connect »

Dr. Diefenbach

New York University Langone Medical Center - Perlmutter Cancer Center
New York, NY United States
  Connect »

Dr. McKinney

Duke University Medical Center
Durham, NC United States
  Connect »

Dr. Smith

University of Washington - Seattle Cancer Care Alliance
Seattle, WA United States
  Connect »

Dr. Durrant

Icon Cancer Care
South Brisbane, Australia
  Connect »

Dr. Bobillo-Varela

Hospital Universitario Vall d'Hebron
Barcelona, Spain
  Connect »

Dr. Provencio-Pulla

Hospital Universitario Puerta de Hierro
Majadahonda, Spain
  Connect »

Dr Shah

Gettysburg Cancer Center
Gettysburg, PA United States
  Connect »

Dr. Goldschmidt

Hadassah Ein Karem Hospital
Jerusalem, Israel
  Connect »

Dr. Gurion

Rabin Medical Center - Beilinson Hospital
Petah tikva, Israel
  Connect »

Dr. Avigdor

The Chaim Sheba Medical Center
Ramat Gan, Israel
  Connect »

Dr. Avivi

Tel Aviv Sourasky Medical Center
Tel Aviv, Israel
  Connect »

Dr Nassi

Azienda Ospedaliero Universitaria Maggiore della Carit di Novara
Novara, Italy
  Connect »

Dr. Bastos Oreiro

Hospital General Universitario Gregorio Mara n
Madrid, Spain
  Connect »

Dr. Perez de Oteyza

HM Universitario Sanchinarro
Madrid, Spain
  Connect »

Dr. Alonso Alonso

Hospital Quir n Madrid
Madrid, Spain
  Connect »

Dr. Gutierrez

Hosp Universitario Salamanca
Salamanca, Spain
  Connect »

Dr. Shah

NNUH NHS Foundation Trust - Norfolk and Norwich University Hospital
Norwich, United Kingdom
  Connect »